Ultra-sensitive dynamic headspace GC-MS/MS method for trace level quantitation of Nitrosamines in Deferiprone API

Significance of the Topic

The presence of nitrosamine genotoxic impurities in pharmaceuticals has become a major regulatory concern. Deferiprone is a high dose iron chelator used for chronic treatment in thalassemia patients. Ensuring ultra trace level quantitation of nitrosamines in Deferiprone API and finished dosage form is critical to patient safety and regulatory compliance.

Objectives and Study Overview

This study aimed to establish and validate a highly sensitive dynamic headspace GC MS MS method capable of detecting six nitrosamine impurities at levels below 0.1 ppb. Key goals included optimizing sample preparation, instrument conditions, and meeting USP general chapter requirements.

Methodology and Instrumentation

Methodology

• Instrumentation Shimadzu GCMS TQ8050 NX with HS 20 NX autosampler
• Column SH PolarD 60 m 0.32 mm id 0.5 micrometer film thickness
• GC oven program from 70°C to 250°C with multi step ramps
• Carrier gas helium at constant linear velocity
• MS electron ionization mode with multiple reaction monitoring
• Headspace conditions include sample heating equilibration and dynamic purge parameters

Sample Preparation

• Deferiprone API weighed and mixed with sodium carbonate
• Headspace vial equilibrated with aqueous sodium hydroxide diluent
• Spiked solutions prepared at LOQ 50 100 and 120 percent levels for validation

Main Results and Discussion

Linearity and Sensitivity

• Six point calibration achieved correlation coefficients above 0.995 for all analytes
• Limits of quantitation ranged below 0.1 ppb based on signal to noise greater than ten
• LOQ precision RSD remained below ten percent

System Performance and Accuracy

• System precision RSD below five percent for area response across six injections
• Spike recovery in the range eighty to one hundred twenty percent demonstrating method accuracy
• Method precision RSD below ten percent at 100 percent spiked level

Practical Benefits and Applications

The validated dynamic headspace GC MS MS procedure offers enhanced sensitivity compared to static headspace techniques. This method is suitable for API quality control and finished dosage form testing to ensure patient safety and adherence to USP guidelines.

Future Trends and Potential Applications

Ongoing developments may integrate automated sample handling and high through put workflows. Miniaturized front end devices and advanced MS detectors could further lower detection limits. Extension to other pharmaceutical compounds and incorporation in regulatory monographs is anticipated.

Conclusion

The dynamic headspace GC MS MS method described provides a robust reliable and ultra sensitive approach for trace level quantitation of nitrosamines in Deferiprone API. The procedure meets stringent regulatory criteria and supports safe pharmaceutical production.

References

• ICH Q2 R2 Validation of Analytical Procedures Test and Methodologies
• USP <1469> General Chapter for Nitrosamine Impurities